生物素标记人CD4/LEU3蛋白(Human CD4/LEU3 Protein)(93130ES)
产品应用
CD4, also known as LEU3 is an approximately 55 kDa type I transmembrane glycoprotein that is expressed predominantly on thymocytes and a subset of mature T lymphocytes. Within the ECD, human CD4 shares approximately 52% aa sequence identity with mouse and rat CD4. CD4 is expressed along with CD8 on double positive T cells during their development in the thymus. CD4 binds directly to MHC class II molecules on antigen presenting cells. This interaction contributes to the formation of the immunological synapse which is focused around the TCR-MHC class II-antigenic peptide interaction. CD4 also functions as a chemotactic receptor for IL-16 and, in human, as a co-receptor for the gp120 surface glycoprotein of HIV-1.
高纯度、高活性、低内毒素、高批间一致性

-25 ~ -15℃保存,收到货之后有效期2年。 复溶后, 无菌条件下,-85 ~ -65℃保存,3个月有效期。
【应用方向】HER2与HER3:ErbB受体家族协同靶向治疗的核心工具蛋白
367
2026-08-31
【应用方向】HER2:抗体药物研发的核心工具蛋白
372
2026-08-31
【应用方向】抗体药研发中常见靶点蛋白及其应用
472
2026-08-31
【应用方向】靶点蛋白在抗体药研发中的应用
337
2026-08-31
【应用方向】GPC3:HCC靶向治疗的核心靶点与药物研发探索
2433
2026-04-24
【应用方向】TROP2:从分子机制到实体瘤靶向治疗的研究进展
2311
2026-04-24
【应用方向】4-1BB-4-1BBL共刺激轴的T细胞活化机制
1404
2026-04-22
【应用方向】TNFR蛋白家族概述
1378
2026-04-21
【应用方向】Klotho蛋白:编织生命之线的抗衰老分子
1595
2026-04-20
【应用方向】药靶明星 | FGFRs家族蛋白解析
1159
2026-04-20
【应用方向】解析Fc受体:抗体药物研发的核心靶点与评价基石
1209
2026-04-20
【应用方向】FcγR家族:抗体药物研发的基石与核心靶点
1325
2026-04-20
【应用方向】CD47-SIRPα轴研究工具与药物开发应用
1072
2026-04-20
【应用方向】HER2靶点蛋白:驱动肿瘤靶向治疗的核心力量
14915
2026-03-02
【技术讲解】细胞因子科学选型--常见问题解答
11532
2026-09-21
南美超级胎牛血清999尝鲜特惠





